Literature DB >> 10717286

Avian immune responses to Mycobacterium avium: the wildfowl example.

R L Cromie1, N J Ash, M J Brown, J L Stanford.   

Abstract

Immunological responses of wildfowl (Order Anseriformes: ducks, geese, swans and screamers) to mycobacteria have been investigated as part of studies to develop a vaccine and diagnostic assay for avian tuberculosis. 10(9) killed Mycobacterium vaccae protected the Cairinini (perching ducks) from avian tuberculosis (p<0.02) but did not achieve statistically significant protection in the other taxonomic tribes. The Cairinini includes the threatened, yet highly susceptible, white-winged duck (Cairina scutulata).Together, loss of cell-mediated responses to common mycobacterial antigens, increased responsiveness to the species specific antigens of M. avium, and increased antibody production are reminiscent of the T(H1) to T(H2) shift seen in mammalian mycobacterial infections. It is speculated that excessive exposure to environmental mycobacteria prior to vaccination is detrimental and common antigens play an important role in wildfowl immunity to mycobacteria. A new vaccination trial using killed M. vaccae is being undertaken. Antibody responses are a useful ante mortem diagnostic indicator in most taxonomic tribes with the exception of the primitive Dendrocygnini (whistling ducks).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717286     DOI: 10.1016/s0145-305x(99)00071-3

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  2 in total

1.  Tuberculosis in Birds: Insights into the Mycobacterium avium Infections.

Authors:  Kuldeep Dhama; Mahesh Mahendran; Ruchi Tiwari; Shambhu Dayal Singh; Deepak Kumar; Shoorvir Singh; Pradeep Mahadev Sawant
Journal:  Vet Med Int       Date:  2011-07-04

2.  Mycobacterium avium subsp. hominissuis infection in a pet parrot.

Authors:  Edmealem Jembere Shitaye; Veronika Grymova; Martin Grym; Roman Halouzka; Alica Horvathova; Monika Moravkova; Vladimir Beran; Jana Svobodova; Lenka Dvorska-Bartosova; Ivo Pavlik
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.